Inhaler Price Caps-Patchwork Progress Without Reform

JAMA Intern Med. 2026 Jan 1;186(1):7-8. doi: 10.1001/jamainternmed.2025.6321.

Authors

Stephen A Mein^{1

2

3}, Rishi K Wadhera^{1

3}

Affiliations

¹ Section of Health Policy, Richard A. and Susan F. Smith Center for Outcomes Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
² Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
³ Harvard Medical School, Boston, Massachusetts.

PMID: 41284270
DOI: 10.1001/jamainternmed.2025.6321

No abstract available

Plain language summary

This Viewpoint describes the public health implications of high inhaler costs for patients with asthma and chronic obstructive pulmonary disease.